Research progress of endothelial lipase as a therapeutic target for coronary heart disease

doi:10.16352/j.issn.1001-6325.2023.09.1443

Abstract

Abstract: Endothelial lipase(EL) is mainly generated by vascular endothelial cells and is responsible for regulating liver lipid metabolism and intestinal lipid absorption. In the inflammatory state, EL can also promote the adhesion and aggregation of macrophages and platelets in the damaged vascular endothelium. EL can also promote the proliferation of damaged vascular endothelial cells, and inhibit the over-expression of EL can reduce the degree of atherosclerosis. However, in acute coronary artery disease and oxidative stress reaction, EL can enhance the antioxidant capacity of high-density lipoprotein cholesterol, reduce the damage of inflammatory reaction to vascular endothelium, enhance the energy metabolism of damaged cardiomyocytes and inhibit apoptosis of damaged cardiomyocytes. As a new therapeutic drug for dyslipidemia and atherosclerosis, endothelial lipase inhibitor needs more extensive clinical trials to clarify its true clinical efficacy, safety and specific clinical application scenarios.

Key words: endothelial lipase, lipid metabolism, inflammatory reaction, atherosclerosis, coronary heart disease (CHD)

CLC Number:

R816.95

SONG Xingming, Harisa·ERKENJIAN, Dilihumal·ABLAITI, GAO Ying. Research progress of endothelial lipase as a therapeutic target for coronary heart disease[J]. Basic & Clinical Medicine, 2023, 43(9): 1443-1447.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/10.16352/j.issn.1001-6325.2023.09.1443

http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2023/V43/I9/1443

References

[1]Jaye M,Lynch KJ,Krawiec J, et al.A novel endothelial-derived lipase that modulates HDL metabolism[J].Nat Genet,1999,2:424-428.
[2]Liu C,Dhindsa D,Almuwaqqat Z, et al.Association between high-density lipoprotein cholesterol levels and adverse cardiovascular outcomes in high-risk populations[J].JAMA Cardiol,2022,7:672-680.
[3]Yang S,Yin RX,Miao L, et al.LIPG SNPs, their haplotypes and gene-environment interactions on serum lipid levels[J].Lipids Health Dis,2019,18:10.doi:10.1186/s12944-018-0942-y.
[4]Nagao M,Miyashita K,Mori K, et al.Serum concentration of full-length-and carboxy-terminal fragments of endothelial lipase predicts future cardiovascular risks in patients with coronary artery disease[J].J Clin Lipidol,2019,13:839-846.
[5]其布热,周红,董莉.内皮酯酶基因多态性与冠心病的关系研究[J].临床和实验医学杂志,2019,18:699-703.
[6]Schilcher I,Kern S,Hrzenjak A, et al.Impact of endothelial lipase on cholesterol efflux capacity of serum and high-density lipoprotein[J].Sci Rep,2017,7:12485.doi:10.1038/s41598-017-12882-7.
[7]Khetarpal SA,Vitali C,Levin MG, et al.Endothelial lipase mediates efficient lipolysis of triglyceride-rich lipoproteins[J].PLoS Genet,2021,17:e1009802.doi:10.1371/journal.pgen.1009802.
[8]Wu L,Soundarapandian MM,Castoreno AB, et al.LDL-cholesterol reduction by angptl3 inhibition in mice is dependent on endothelial lipase[J].Circ Res,2020,127:1112-1114.
[9]Wang C,Nishijima K,Kitajima S, et al.Increased hepatic expression of endothelial lipase inhibits cholesterol diet-induced hypercholesterolemia and atherosclerosis in transgenic rabbits[J].Arterioscler Thromb Vasc Biol,2017,37:1282-1289.
[10]Wu YE,Ma L,Zhang H, et al.Significant association between the endothelial lipase gene 584C/T polymorphism and coronary artery disease risk[J].Biosci Rep,2020,40.doi:10.1042/BSR20200027.
[11]Schilcher I,Stadler JT,Lechleitner M, et al.Endothelial lipase modulates paraoxonase 1 content and arylesterase activity of HDL[J].Int J Mol Sci,2021,22.doi:10.3390/ijms22020719.
[12]陈永宏,杨松,周建中.阿托伐他汀减轻肾性高血压大鼠血管重构[J].基础医学与临床,2010,30:383-388.
[13]Trimarco V,Izzo R,Morisco C, et al.High HDL(high-density lipoprotein) cholesterol increases cardiovascular risk in hypertensive patients[J].Hypertension,2022,79:2355-2363.
[14]Yue X Wu M,Jiang H, et al.Endothelial lipase is upregulated by interleukin-6 partly via the p38 MAPK and p65 NF-κB signaling pathways[J].Mole Med Reports,2016,14: 1979-1985.
[15]Dalan AB,Toptaş B,Buǧra Z, et al.The effects of endothelial lipase gene (LIPG) variants on inflammation marker levels and atherosclerosis development[J].Mol Biol Rep,2013,40:5143-5149.
[16]Cadenas C,Vosbeck S,Edlund K, et al.LIPG-promoted lipid storage mediates adaptation to oxidative stress in breast cancer[J].Int J Cancer,2019,145:901-915.
[17]Nakajima H,Ishida T,Satomi-Kobayashi S, et al.Endothelial lipase modulates pressure overload-induced heart failure through alternative pathway for fatty acid uptake[J].Hypertension,2013,61:1002-1007.
[18]Schilcher I,Ledinski G,Radulović S, et al.Endothelial lipase increases antioxidative capacity of high-density lipoprotein[J].Biochim Biophys Acta Mol Cell Biol Lipids,2019,1864:1363-1374.
[19]Wan A,Rodrigues B.Endothelial cell-cardiomyocyte crosstalk in diabetic cardiomyopathy[J].Cardiovasc Res,2016,111:172-183.
[20]Yan H,Niimi M,Wang C, et al.Endothelial lipase exerts its anti-atherogenic effect through increased catabolism of β-VLDLs[J].J Atheroscler Thromb,2021,28:157-168.
[21]Kobayashi J.Which is the Best predictor for the develop-ment of atherosclerosis among circulating lipoprotein lipase, hepatic lipase, and endothelial lipase?[J].J Atheroscler Thromb,2019,26:758-759.
[22]Yu X,Lu J,Li J, et al.Serum triglyceride lipase concentrations are independent risk factors for coronary artery disease and in-stent restenosis[J].J Atheroscler Thromb,2019,26:762-774.
[23]Tora G,Kim SH,Pi Z, et al.Identification of reversible small molecule inhibitors of endothelial lipase (EL) that demonstrate HDL-C increase in vivo[J].J Med Chem,2020,63:1660-1670.
[24]Johnson JA,Tora G,Pi Z, et al.Sulfonylated benzothia-zoles as inhibitors of endothelial lipase[J].ACS Med Chem Lett,2018,9:1263-1268.
[25]Ruff CT,Koren MJ,Grimsby J, et al.LEGACY: phase 2a trial to evaluate the safety, pharmacokinetics, and pharmacodynamic effects of the anti-EL(endothelial lipase) antibody MEDI5884 in patients with stable coronary artery disease[J].Arterioscler Thromb Vasc Biol,2021,41:3005-3014.
[26]Meng W,Adam LP,Behnia K, et al.Benzothiazole-based compounds as potent endothelial lipase inhibitors[J].Bioorg Med Chem Lett,2019,29:126673.doi:10.1016/j.bmcl.2019.126673.